MOACM
ANIP icon

Mutual of America Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Mutual of America Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,401
Closed -$77K – 1459
2022
Q3 		$77K Buy
2,401
+201
+9% +$6.88K ﹤0.01% 1564
2022
Q2 		$65K Buy
2,200
+367
+20% +$10.6K ﹤0.01% 1573
2022
Q1 		$52K Buy
1,833
+354
+24% +$13.2K ﹤0.01% 1607
2021
Q4 		$68K Buy
1,479
+187
+14% +$8.04K ﹤0.01% 1593
2021
Q3 		$42K Sell
1,292
-119
-8% -$3.7K ﹤0.01% 1629
2021
Q2 		$49K Buy
1,411
+125
+10% +$4.25K ﹤0.01% 1638
2021
Q1 		$46K Buy
1,286
+87
+7% +$2.72K ﹤0.01% 1641
2020
Q4 		$35K Buy
1,199
+48
+4% +$1.38K ﹤0.01% 1635
2020
Q3 		$32K Buy
1,151
+691
+150% +$20.6K ﹤0.01% 1605
2020
Q2 		$15K Buy
460
+53
+13% +$1.9K ﹤0.01% 1594
2020
Q1 		$17K Buy
407
+74
+22% +$3.94K ﹤0.01% 1514
2019
Q4 		$21K Sell
333
-11
-3% -$729 ﹤0.01% 1551
2019
Q3 		$25K Buy
344
+44
+15% +$3.29K ﹤0.01% 1520
2019
Q2 		$25K Buy
300
+63
+27% +$4.48K ﹤0.01% 1519
2019
Q1 		$17K Buy
237
+29
+14% +$1.71K ﹤0.01% 1549
2018
Q4 		$9K Buy
208
+51
+32% +$2.67K ﹤0.01% 1621
2018
Q3 		$9K Buy
157
+124
+376% +$7.59K ﹤0.01% 1634
2018
Q2 		$2K Buy
+33
New +$2.06K ﹤0.01% 1585
2016
Q4 		– Sell
-29,978
Closed -$1.99M – 1212
2016
Q3 		$1.99M Hold
29,978
– – 0.04% 752
2016
Q2 		$1.67M Hold
29,978
– – 0.04% 784
2016
Q1 		$1.01M Sell
29,978
-200
-0.7% -$6.78K 0.02% 998
2015
Q4 		$1.36M Buy
30,178
+178
+0.6% +$7.66K 0.03% 846
2015
Q3 		$1.19M Buy
30,000
+8,000
+36% +$455K 0.03% 908
2015
Q2 		$1.36M Sell
22,000
-2,760
-11% -$164K 0.03% 897
2015
Q1 		$1.55M Sell
24,760
-69,868
-74% -$4.25M 0.03% 831
2014
Q4 		$5.34M Buy
+94,628
New +$4.17M 0.12% 196
2014
Q2 		– Sell
-54,737
Closed -$1.72M – 1254
2014
Q1 		$1.72M Sell
54,737
-45,820
-46% -$1.22M 0.04% 749
2013
Q4 		$2.02M Buy
100,557
+91,974
+1,072% +$1.19M 0.05% 655
2013
Q3 		$84K Buy
+8,583
New +$61.9K ﹤0.01% 1137

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Mutual of America Capital Management's ANIP Position: Q4 2022 in Review

Mutual of America Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2022, closing a stake of 2,401 shares — an estimated $77K sold.

Mutual of America Capital Management first reported a position in ANIP in Q3 2013 and held it in 29 quarters. The position peaked at $5.34M in Q4 2014. 126 funds tracked by Wall St. Rank hold ANIP as of Q4 2022.

  • Mutual of America Capital Management reported no remaining ANI Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 2,401 ANI Pharmaceuticals shares in Q4 2022, an estimated $77K.
  • Mutual of America Capital Management first reported a position in ANI Pharmaceuticals in Q3 2013 and held it in 29 quarters.
  • Mutual of America Capital Management's ANI Pharmaceuticals position peaked at $5.34M in Q4 2014.
  • 126 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.